Oral Health in Africa: Promoting Collaborative Solutions

By Crystal Lubbe

April 1, 2025

Is oral health taking a back seat in public health discussions in Africa? This article brings to the forefront the pressing challenges confronting oral health across the continent. Specifically, it highlights the widespread prevalence of untreated dental diseases and the critical shortage of oral health professionals—with the number of dentists ranging from just 1.77 to as few as 0.03 per 10,000 people. Consequently, millions continue to suffer from a high burden of untreated oral conditions, including dental caries, periodontal disease, oral cancers, HIV-related complications, and noma, all of which severely compromise quality of life.

Key Insights:

  • Oral Disease Burden: Untreated dental caries and periodontal disease are widespread in Africa. Regional variations are influenced by socioeconomic and dietary factors.
  • Workforce and Policy Gaps: Many countries face a critical shortage of dentists and dental care assistants. Inadequate oral health policies worsen the problem.
  • Collaborative Solutions: Partnerships among healthcare providers, industry, civil society, and academia are key to improving oral health outcomes.
  • Prevalence of Oral disease: Untreated caries (5+ years) is highest in Northern Africa (33.72%), severe periodontal disease (15+ years) in Western Africa (26.75%), and new lip and oral cavity cancer cases in Northern Africa (median: 269.5 cases). See Table 1 for details.
Table 1: Burden of major oral diseases in Africa (Foláyan et al 2015)

Background Context:

WHO reports Africa has seen the largest global rise in oral diseases over 30 years. Nearly 44% of the population is affected. Only 57% of African countries have a national oral health policy. The region spends less than US$1 per person annually on oral health. WHO’s Global Oral Health Strategy aims for universal coverage by 2030, focusing on prevention and community-based interventions.

Implications:

  • Health Economics: Oral diseases cause significant economic losses due to healthcare costs and lost productivity. Prevention and better care access can bring long-term benefits.
  • Health Outcomes: Integrating oral health into primary healthcare and community interventions can improve overall well-being.
  • Policy and Research: Strengthening local research is vital for evidence-based policies.

To address these issues effectively, stakeholders must take coordinated action. In particular, integrating oral health into national public health policies remains essential for expanding access to care. Furthermore, national dental associations, working in partnership with public health institutions and international organisations, can drive meaningful policy change and promote better resource allocation. Through such collaborative efforts, Africa can begin to close the oral health gap and deliver improved outcomes for its population. For more details, see the original article.

 

Reference url

Recent Posts

access to medicines
         

Quantifying EU Medicine Access Challenges

🔍 Are we creating a healthcare system that truly works for everyone?

Recent findings from EFPIA shed light on alarming inequities in access to medicines across Europe, showing that only 46% of approved drugs are available to patients this year. With significant delays affecting smaller markets and critical cancer treatments, this article explores the systemic barriers at play and innovative solutions proposed to ensure fair access.

Dive into the full article to uncover how we can collectively shape a more equitable healthcare landscape.

#SyenzaNews #healthcare #MarketAccess

UK Medicine Payment Rates
      

Revitalizing Innovation: The Impact of UK Medicine Payment Rates

💡 Are the UK’s medicine payment rates stifling innovation in life sciences?

Recent analysis reveals that the staggering 23.5% payment rate for pharmaceuticals is not just limiting NHS spending but also curtailing R&D investments, delaying new drug launches, and threatening workforce stability. If we can lower these rates to below 10%, we could unleash significant growth and restore the UK’s competitive edge in the global life sciences landscape.

Discover the critical insights and recommendations that could reshape the future of healthcare in the UK.

#SyenzaNews #healthcarepolicy #innovation

Blinatumomab benefit assessment
            

Blinatumomab Benefit Assessment for ALL and Health Economics

🚀 How does a groundbreaking therapy change the landscape of acute lymphoblastic leukemia treatment?

The recent benefit assessment of Blinatumomab by the German Federal Joint Committee reveals critical insights into its potential as a consolidation therapy for adults with Philadelphia chromosome-negative B-cell precursor ALL. With its orphan drug status promising automatic benefits, the article explores the implications of its high cost and economic impacts, shedding light on the balance needed between innovation and sustainability in healthcare.

Jump into the full analysis to understand how this could impact clinical practice and health economics.

#SyenzaNews #HealthEconomics #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.